FlexifyMe: Transforming Health-Tech with Rs 20 Crore Funding
Health-tech company FlexifyMe has successfully secured Rs 20 crore (approximately $2.4 million) in pre-Series A funding, led by IvyCap Ventures, alongside contributions from Signal Ventures and existing investors. Earlier, the firm garnered $1 million in a seed funding round spearheaded by Flipkart Ventures and gained attention on Shark Tank India Season 3, resulting in an investment from Namita Thapar of Emcure.
Utilisation of New Funds
The newly acquired funds will be directed towards expanding its hybrid care services, which includes both online and offline centres. Furthermore, the investment will support the establishment of advanced posture and gait analysis labs and the enhancement of clinical research partnerships, according to a recent press release from FlexifyMe.
About FlexifyMe
Founded in 2021 by Manjeet Singh and Amit Bhayani, FlexifyMe integrates AI-driven posture and motion analysis with professional physiotherapy to pinpoint the primary causes of chronic musculoskeletal pain. The company’s approach shifts away from traditional, symptom-based care towards more precise, data-driven interventions, thus helping to minimise unnecessary procedures and bolster long-term patient results.
Vision and Mission
Manjeet Singh, co-founder of FlexifyMe, remarked that by merging technology with licensed physiotherapists and detailed progress tracking, the aim is to transform the path to a pain-free life into a scientific, objective, and measurable journey. This funding will enable the company to scale its capabilities, assisting millions in avoiding needless surgeries while returning to their beloved activities and reclaiming significant quality of life.
Services Offered by FlexifyMe
Based in Pune, the platform provides real-time one-on-one interactions with certified instructors, custom-tailored programmes, and guided video sessions, combining traditional wisdom with state-of-the-art technology. FlexifyMe claims to have gained the trust of thousands of users across India and international markets. The company collaborates with enterprises, insurers, and healthcare networks to provide clinically validated outcomes.